Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.52
At close: May 15 EDT
$15.52
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Tourmaline Bio Analyst Ratings and Price Targets | NASDAQ:TRML | Benzinga
Tourmaline Bio Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Tourmaline Bio Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Chardan Capital
Wedbush
LifeSci Capital
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Tourmaline Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/05/2025 | Buy Now | — | HC Wainwright & Co. | Yi Chen56% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2025 | Buy Now | — | Chardan Capital | Daniil Gataulin40% | $70 → $70 | Maintains | Buy | Get Alert |
| 04/23/2025 | Buy Now | — | Chardan Capital | Daniil Gataulin40% | → $70 | Initiates | → Buy | Get Alert |
| 03/14/2025 | Buy Now | — | Wedbush | Laura Chico46% | $42 → $43 | Maintains | Outperform | Get Alert |
| 03/14/2025 | Buy Now | — | HC Wainwright & Co. | Yi Chen56% | $49 → $50 | Maintains | Buy | Get Alert |
| 03/06/2025 | Buy Now | — | Wedbush | Laura Chico46% | → $42 | Initiates | → Outperform | Get Alert |
| 02/24/2025 | Buy Now | — | LifeSci Capital | Jimmy Shan63% | → $58 | Initiates | → Outperform | Get Alert |
| 12/11/2024 | Buy Now | — | Guggenheim | Yatin Suneja47% | — | Reiterates | Buy → Buy | Get Alert |
| 12/11/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer52% | $25 → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 12/11/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen56% | $49 → $49 | Reiterates | Buy → Buy | Get Alert |
| 12/06/2024 | Buy Now | — | BMO Capital | Etzer Darout45% | → $50 | Initiates | → Outperform | Get Alert |
| 11/11/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen56% | $48 → $49 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen56% | $48 → $48 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen56% | $48 → $48 | Reiterates | Buy → Buy | Get Alert |
| 03/25/2024 | Buy Now | — | Truist Securities | Robyn Karnauskas54% | → $74 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | Buy Now | — | Jefferies | Roger Song34% | $41 → $72 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen56% | $48 → $48 | Reiterates | Buy → Buy | Get Alert |
| 12/15/2023 | Buy Now | — | Jefferies | Roger Song34% | → $41 | Initiates | → Buy | Get Alert |
| 11/17/2023 | Buy Now | — | Truist Securities | Robyn Karnauskas54% | → $43 | Initiates | → Buy | Get Alert |
| 10/31/2023 | Buy Now | — | Guggenheim | Yatin Suneja47% | → $50 | Initiates | → Buy | Get Alert |
| 10/25/2023 | Buy Now | — | Piper Sandler | Yasmeen Rahimi55% | → $65 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Tourmaline Bio (TRML) stock?
The latest price target for Tourmaline Bio (NASDAQ:TRML) was reported by HC Wainwright & Co. on May 5, 2025. The analyst firm set a price target for $50.00 expecting TRML to rise to within 12 months (a possible 222.16% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tourmaline Bio (TRML)?
The latest analyst rating for Tourmaline Bio (NASDAQ:TRML) was provided by HC Wainwright & Co., and Tourmaline Bio reiterated their buy rating.
When was the last upgrade for Tourmaline Bio (TRML)?
There is no last upgrade for Tourmaline Bio
When was the last downgrade for Tourmaline Bio (TRML)?
There is no last downgrade for Tourmaline Bio.
When is the next analyst rating going to be posted or updated for Tourmaline Bio (TRML)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tourmaline Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tourmaline Bio was filed on May 5, 2025 so you should expect the next rating to be made available sometime around May 5, 2026.
Is the Analyst Rating Tourmaline Bio (TRML) correct?
While ratings are subjective and will change, the latest Tourmaline Bio (TRML) rating was a reiterated with a price target of $50.00 to $50.00. The current price Tourmaline Bio (TRML) is trading at is $15.52, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
